Business Standard

Lactose (India) Share Price

Know More
Stock not traded

164.300.70 (0.43%)

04:01 PM,18th Apr 2024

BSE : 524202


Sector : Health care

ISIN Code : INE058I01013

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 18 2024 | 04:01 PM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)

Face Value


52-WK High


52-WK High Date

Invalid date

52-WK Low


52-WK Low Date

Invalid date

All Time High


All Time High Date

Invalid date

All Time Low


All Time Low Date

Invalid date

Lactose (India) Ltd

Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose which is used as an ingredient in pharmaceutical products as well as in the dairy food confectionery and beverage industries. The company also manufactures dairy whitener dairy calcium whey powder casein caseinate butter and ghee. Further they engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation Fluid bed drying compaction blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai Delhi Chennai Bangalore Calcutta Hyderabad and Ahmedabad. The company set up a project to manufacture lactose IP/BP grade an import substitute with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval Pune a subsidiary of Alfa Laval Sweden. In January 1994 the company commenced commercial production of Lactose. In the year 1994 the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections namely capsule section tablet section and indictable section.During the year 1995-96 the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condensed milk casein powder.During the year 2004-05 the company streamlined their pharmaceutical plant and entered into long-term contract manufacturing for one of the leading multinational company. They invested substantially in upgrading and renovating the Pharmaceutical facilities as per the requirement of the new Schedule M as per the directives from the Food and Drug Administration. Also they started a new equipment manufacture assemble and export for Projects division in Kandla SEZ (Special Economic Zone).During the year 2006-07 the company undertook major expansion programme at their existing production site for manufacturing of value added product LACTULOSE which is a forward integration of their existing product LACTOSE.During the year 2007-08 the company successfully implemented the task undertaken last year and commissioned the new liquid orals division. During the year 2008-09 the company started manufacturing of Liquid Formulations.The Company in 2010 formed strategic alliance with Kerry Group of Ireland for contract manufacturing Of lactose 10000 Mt / Annum.It started manufacturing for Dr Reddy's for their Liquid Oral Bottles in 2015. In 2016 it started Lactulose Manufacturing API Plant. In 2022 it started own marketing & sales of Lactose Monohydrate under the banner of Lactose (India) Limited.The Company in 2023 launched production of Lactulose with state of art manufacturing facility. The Plant produces Lactulose Concentrate USP & Lactulose Solution USP/EP. It broadened the horizons by getting into contract manufacturing of Tablets Liquid orals & Manufacturing of Finished Formulations.

Lactose (India) Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]33.62
P/B Ratio (₹) [S]4.89
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week10.53%%-3.40-3.33%
1 Month17.15%%-0.36-0.27%
3 Month13.98%%1.832.49%
6 Month166.94%%10.0411.82%
1 Year266.01%%21.3724.55%
3 Year584.58%%48.4550.47%

Company Info

Company Information

Chairman & Managing Director : Atul Maheshwari

Whole Time Director & CFO : S M Maheshwari

Independent Non Exe. Director : Pramod Kalani

Independent Non Exe. Director : G K Sarda

Independent Non Exe. Director : Dhaval J Soni

Registered Office: Survey No 6, Village Poicha (Rania) Savli,Vadodara,Gujarat-391780 Ph: 91-02667-244308/244729